The prognostic value of histological typing in nasopharyngeal carcinoma

Pathmanathan, 1995, Clonal proliferations of cells infected with Epstein–Barr virus in preinvasive lesions related to nasopharyngeal carcinoma, N Engl J Med, 333, 693, 10.1056/NEJM199509143331103

Hong Kong Cancer Registry, Hospital Authority. Nasopharyngeal cancer. In: Hong Kong Cancer Stat 2007; 2007.

Baujat, 2006, Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma, Cochrane Database Syst Rev, 18, CD004329

Chan, 2011, Can the analysis of ERCC1 expression contribute to individualized therapy in nasopharyngeal carcinoma?, Int J Radiat Oncol Biol Phys, 79, 1414, 10.1016/j.ijrobp.2009.12.072

Chan JKC, Bray F, Mc Carron P, Foo W, Lee AWM, Yip T, et al. Nasopharyngeal carcinoma. In: Barnes EL, Eveson JW, Reichart P, Sdransky D, editors. Pathology and genetics of head and neck tumours. Kleihues P, Sobin LH, editors. World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2005. p. 85–97.

Wu, 1991, Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein–Barr virus in formalin-fixed paraffin-embedded carcinoma specimens, Am J Pathol, 138, 1461

Saw, 1985, Prognosis and histology in stage I nasopharyngeal carcinoma (NPC), Int J Radiat Oncol Biol Phys, 11, 893, 10.1016/0360-3016(85)90110-5

Reddy, 1995, Prognostic significance of keratinization in nasopharyngeal carcinoma, Am J Otolaryngol, 16, 103, 10.1016/0196-0709(95)90040-3

Shanmugaratnam, 1979, Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics, Cancer, 44, 1029, 10.1002/1097-0142(197909)44:3<1029::AID-CNCR2820440335>3.0.CO;2-5

Olaussen, 2006, DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy, N Engl J Med, 355, 983, 10.1056/NEJMoa060570

Sun, 2011, Expression of excision repair cross-complementation group 1 as predictive marker for nasopharyngeal cancer treated with concurrent chemoradiotherapy, Int J Radiat Oncol Biol Phys, 80, 655, 10.1016/j.ijrobp.2010.02.061

Lee, 2010, High expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with nasopharyngeal cancer, Oral Oncol, 46, 209, 10.1016/j.oraloncology.2009.12.007